Drug Discovery

Metabolomics is a forthcoming innovation framework which includes exploratory investigation of metabolic profiles. Because of its various applications in preclinical and clinical research, it turned into a helpful apparatus for medication disclosure and medication improvement process. This survey covers the short blueprint of the instrumentation and elucidation of metabolic profiles. The uses of metabolomics have an impressive extension in the pharmaceutical business, nearly at each progression from medication disclosure to clinical improvement. These incorporate discovering drug target, potential wellbeing, and adequacy biomarkers and components of medication activity, the approval of preclinical exploratory models against human sickness profiles, and the disclosure of clinical security and viability biomarkers.


  • Track 1-1 Drug target identification and validation
  • Track 2-2 ADMET screening
  • Track 3-3 Challenges in Pharmacokinetics
  • Track 4-4 Applications in Clinical studies
  • Track 5-5 Potential Biomarkers

Related Conference of Medical